Literature DB >> 12050581

Management of esophageal strictures in children with recessive dystrophic epidermolysis bullosa.

Ricardo O Castillo1, Yinka K Davies, Yuan-Chi Lin, Manuel Garcia, Harvey Young.   

Abstract

BACKGROUND: Recessive dystrophic epidermolysis bullosa is a rare, genetically transmitted skin disorder characterized by blister formation and scarring in response to minor trauma. One of the most debilitating features of the disease is the development of esophageal strictures, which produces profound dysphagia, exacerbating an already highly compromised nutritional status common to these patients. Due to the extreme fragility of epithelial surfaces, the optimal therapeutic approach to esophageal strictures in this setting has not been established.
METHODS: We have developed an approach to treatment of esophageal strictures in children with epidermolysis bullosa combining upper endoscopy using small caliber endoscopes, endotracheal intubation, and fluoroscopically assisted balloon dilatation. We report our experience using this technique in 22 children who have undergone a total of 109 dilatations.
RESULTS: Upper endoscopy, endotracheal intubation, and balloon dilatation were well tolerated by even very young children with epidermolysis bullosa. Dysphagia was markedly reduced post-procedure, permitting resumption of normal diet for age, including solids, within six hours of the procedure. Post-procedure recovery has been rapid and does not require admission to the hospital. Complications have been infrequent, minor, and limited to the first year of our experience. The mean interval between dilatations for all children is 11 months. All children have gained weight, and have not required steroids or phenytoin.
CONCLUSIONS: Balloon dilatation is a safe and effective therapy for esophageal strictures in children with recessive dystrophic epidermolysis bullosa. Limited upper endoscopy and endotracheal intubation are well tolerated by these children. This approach should be considered as primary therapy in this clinical setting.

Entities:  

Mesh:

Year:  2002        PMID: 12050581     DOI: 10.1097/00005176-200205000-00012

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  4 in total

1.  Histopathological features of gastrointestinal mucosal biopsy specimens in children with epidermolysis bullosa.

Authors:  N Shah; E Freeman; A Martinez; J Mellerio; V V Smith; K J Lindley; N J Sebire
Journal:  J Clin Pathol       Date:  2006-10-17       Impact factor: 3.411

2.  Approach and Safety of Esophageal Dilation for Treatment of Strictures in Children With Epidermolysis Bullosa.

Authors:  Bradley T Anderson; James A Feinstein; Robert E Kramer; Michael R Narkewicz; Anna L Bruckner; David E Brumbaugh
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-12       Impact factor: 2.839

3.  Non-endoscopic percutaneous gastrostomy placement in children with recessive dystrophic epidermolysis bullosa.

Authors:  Wolfgang Stehr; Michael K Farrell; Anne W Lucky; Neil D Johnson; John M Racadio; Richard G Azizkhan
Journal:  Pediatr Surg Int       Date:  2007-12-20       Impact factor: 1.827

4.  Otorhinolaryngological and esophageal manifestations of epidermolysis bullosa.

Authors:  Rodrigo Santana Fantauzzi; Mariana Oliveira Maia; Flávia Coelho Cunha; Rodrigo Vidal Simões; Denise Utsch Gonçalves; Amélio Ferreira Maia
Journal:  Braz J Otorhinolaryngol       Date:  2008 Sep-Oct
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.